The MarketWatch News Department was not involved in the creation of this content. bioAffinity Technologies' noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to ...

In a 2024 Journal of Thoracic Oncology review, Haiquan Chen, MD, PhD, of Fudan University Shanghai Cancer Center in China, and colleagues backed the use of selective lymph node dissection (LND) to ...

bioAffinity Technologies’ noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to confirmed malignancy and immediate treatment Ground-glass nodules appear in ...

bioAffinity Technologies’ noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to confirmed malignancy and immediate treatment SAN ANTONIO--(BUSINESS WIRE)-- ...

Multi-centre clinical study of cell-free DNA mutations in benign and malignant lung lesions. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This abstract does not include a full ...

Lung-RADS in clinical practice achieved excellent performance for lung cancer risk assessment on follow-up screening CT examinations, although strict application did downgrade some malignancies Noting ...

Benign lung nodules can have a few different causes. These include current and past infections in the lungs and inflammation in the body from a condition like rheumatoid arthritis. A lung nodule is a ...

The process of staging lung cancer accurately plays a major role in establishing treatment options and predicting survival. Proper lung cancer staging demands a thorough understanding of TNM-8, which ...

A robotic scope that is so thin it can enter some of the smallest chambers in the lung helps detect cancers earlier than other methods, according to Dr. Anil Magge of St. Francis Hospital. He ...